Ercc5 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Ercc5 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The ERCC5 gene (also known as XPG) encodes a structure-specific endonuclease essential for nucleotide excision repair (NER). XPG cleaves 3' to DNA lesions during NER, completing the excision of the damaged oligonucleotide. ERCC5 mutations cause xeroderma pigmentosum (XP-G group) and Cockayne syndrome, with severe consequences including neurodegeneration and premature aging.
Function
ERCC5 (XPG) is a structure-specific endonuclease with essential roles in:
Nucleotide Excision Repair
Recognizes and cleaves DNA 3' to various lesions
Essential for complete removal of UV-induced pyrimidine dimers
Removes bulky chemical adducts, crosslinks, and other distortions
Part of the core NER machinery with ERCC1-ERCC4
Transcription-Coupled Repair (TCR)
Specifically removes lesions from actively transcribed DNA strands
Critical for preventing transcription-blocking damage in [neurons](/entities/neurons)
Protects against RNA polymerase II stalling
Structure
Contains N-terminal and C-terminal nuclease domains
Recognizes DNA bubble structures
Makes precise incisions at lesion boundaries
Disease Associations
Xeroderma Pigmentosum (XP-G)
ERCC5 mutations cause XP complementation group G
Extreme photosensitivity
10,000-fold increased skin cancer risk
Variable neurological degeneration
Cockayne Syndrome (CS)
ERCC5 mutations can cause CS type II
Severe developmental defects
Progeroid features
Neurological dysfunction
Sunlight-sensitive face
XP/CS Complex
Some patients show features of both XP and CS
Combined DNA repair defects
Severe neurodegeneration
Neurodegeneration
Progressive neuronal loss
Ataxia and movement disorders
Cognitive decline
Hearing loss
Retinal degeneration
Accumulated DNA damage in neurons
Cancer
Dramatically increased skin cancer risk
Early onset skin malignancies
Expression
ERCC5 is expressed in most tissues:
Highest levels in:
Testis
Ovary
Brain
Skin
Moderate expression in:
Liver
Kidney
Lung
In the brain:
Detected in neurons and glia
Important for maintaining neuronal genomic integrity
Critical for transcription-coupled repair in long-lived neurons
The study of Ercc5 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data